ChemoCentryx Inc. (CCXI) Moves Higher on Volume Spike for October 04

Equities Staff  |

ChemoCentryx Inc. (CCXI) traded on unusually high volume on Oct. 04, as the stock gained 2.94% to close at $8.41. On the day, ChemoCentryx Inc. saw 221,885 shares trade hands on 1,806 trades. Considering that the stock averages only a daily volume of 126,610 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $10.80 and $5.19 over the last 52-weeks, its 50-day SMA is now $7.85, and its 200-day SMA $7.64. ChemoCentryx Inc. has a P/B ratio of 10.01.

ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

Headquartered in Mountain View, CA, ChemoCentryx Inc. has 62 employees and is currently under the leadership of CEO Thomas J. Schall.

For a complete fundamental analysis analysis of ChemoCentryx Inc., check out’s Stock Valuation Analysis report for CCXI.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on ChemoCentryx Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: CCXI’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor,; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

GTX Corp

GTX Corp, along with its subsidiaries, is engaged in design, development, manufacturing, distribution and sales of products and services in the GPS and BLE wearable technology personal location and wandering…